Clinical Study Evaluating the Efficacy and Safety of Montelukast in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Montelukast (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Pharmacodynamics
- 10 Sep 2020 New trial record